価格表

在庫・価格 : 2025年10月08日 10時44分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Rat VEGF 164 Affinity Purified Polyclonal Ab
データシート※最新のデータシートでない場合があります
AF564-SP RSDアールアンドディー システムズ
R&D Systems, Inc.
25 μg ¥28,000
(未発注)
追加

在庫・価格 : 2025年10月08日 10時44分 現在

Anti-Rat VEGF 164 Affinity Purified Polyclonal Ab

  • 商品コード:AF564-SP
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥28,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Khalili S et al. The effect of a single anti-Vascular Endothelial Growth Factor injection on neonatal growth and organ development: In-vivo study. Exp Eye Res 2018 04;169:54-59
Khalili S et al
2018/01/01
Species: Rat, Applications: In Vivo PubMed
2 Asano D et al. Cellular Mechanisms of Angiogenesis in Neonatal Rat Models of Retinal Neurodegeneration. Int J Mol Sci 2019 Sep;20(19)
Asano D et al
2019/01/01
Species: Rat, Applications: ICC PubMed
3 Advani A et al. Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions. Proc. Natl. Acad. Sci. U.S.A. 2007 Sep;104(36):14448-53
Advani A et al
2007/01/01
Species: Rat, Applications: Neutralization PubMed
4 Wang H et al. Quantitative analyses of retinal vascular area and density after different methods to reduce VEGF in a rat model of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2014 Feb;55(2):737-44
Wang H et al
2014/01/01
Species: Rat, Applications: Neutralization PubMed
5 Hartnett ME et al. Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease. Invest. Ophthalmol. Vis. Sci. 2008 Jul;49(7):3107-14
Hartnett ME et al
2008/01/01
Species: Rat, Applications: Neutralization PubMed
6 Baron-Menguy C et al. Effects of red wine polyphenols on postischemic neovascularization model in rats: low doses are proangiogenic, high doses anti-angiogenic. FASEB J. 2007 Nov;21(13):3511-21
Baron-Menguy C et al
2007/01/01
Species: Rat, Applications: Neutralization PubMed
7 McCloskey M et al. Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2013 Mar;54(3):2020-6
McCloskey M et al
2013/01/01
Species: Rat, Applications: Neutralization PubMed
8 Melly L et al. Myocardial infarction stabilization by cell-based expression of controlled Vascular Endothelial Growth Factor levels. J. Cell. Mol. Med. 2018 May;22(5):2580-2591
Melly L et al
2018/01/01
Species: Rat, Applications: IHC PubMed
9 Imberti B et al. Renal primordia activate kidney regenerative events in a rat model of progressive renal disease. PLoS ONE 2015;10(3):e0120235
Imberti B et al
2015/01/01
Species: Rat, Applications: IHC PubMed
10 Shimojo N et al. Contributory role of VEGF overexpression in endothelin-1-induced cardiomyocyte hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 2007 Jul;293(1):H474-81
Shimojo N et al
2007/01/01
Species: Rat, Applications: Neutralization PubMed
11 Deliyanti D et al. FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy. PLoS ONE 2015;10(7):e0134392
Deliyanti D et al
2015/01/01
Species: Rat, Applications: IHC-P PubMed
12 Mirabelli P et al. Genome-wide expression differences in anti-Vegf and dexamethasone treatment of inflammatory angiogenesis in the rat cornea. Sci Rep 2017 Aug;7(1):7616
Mirabelli P et al
2017/01/01
Species: Rat, Applications: Neutralization PubMed
13 Yeh WL et al. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression. Mol. Pharmacol. 2007 Aug;72(2):440-9
Yeh WL et al
2007/01/01
Species: Rat, Applications: Neutralization PubMed
14 Lind T et al. Bones in human CYP26B1 deficiency and rats with hypervitaminosis A phenocopy <i>Vegfa</i> overexpression. Bone Rep 2018 Dec;9:27-36
Lind T et al
2018/01/01
Species: Rat, Applications: IHC PubMed
15 Yeh WL et al. Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia. Mol. Pharmacol. 2008 Jan;73(1):170-7
Yeh WL et al
2008/01/01
Species: Rat, Applications: Neutralization PubMed
16 Daniel C et al. Long-term gene therapy with thrombospondin 2 inhibits TGF-&#x3B2; activation, inflammation and angiogenesis in chronic allograft nephropathy. PLoS ONE 2013;8(12):e83846
Daniel C et al
2013/01/01
Species: Rat, Applications: IHC PubMed
17 Irani Y et al. Production of scFv antibody fragments from a hybridoma with functional activity against human vascular endothelial growth factor. Hybridoma (Larchmt) 2009 Jun;28(3):205-9
Irani Y et al
2009/01/01
Species: Human, Applications: Binding Assay PubMed
18 Westenbrink BD et al. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure. Cardiovasc. Res. 2010 Jul;87(1):30-9
Westenbrink BD et al
2010/01/01
Species: Rat, Applications: Neutralization PubMed
19 Lin HH et al. Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1. J. Mol. Cell. Cardiol. 2008 Jul;45(1):44-55
Lin HH et al
2008/01/01
Species: Mouse, Applications: Neutralization PubMed
20 Dharmani P et al. The probiotic mixture VSL#3 accelerates gastric ulcer healing by stimulating vascular endothelial growth factor. PLoS ONE 2013;8(3):e58671
Dharmani P et al
2013/01/01
Species: Rat, Applications: Neutralization PubMed
21 Marko SB et al. VEGF promotes vascular sympathetic innervation. Am. J. Physiol. Heart Circ. Physiol. 2008 Jun;294(6):H2646-52
Marko SB et al
2008/01/01
Species: Rat, Applications: Neutralization PubMed
22 Al Asoom LI. Coronary angiogenic effect of long-term administration of Nigella sativa. BMC Complement Altern Med 2017 Jun;17(1):308
Al Asoom LI
2017/01/01
Species: Rat, Applications: IHC PubMed
  • No.: 1
  • 文献情報:
    Khalili S et al. The effect of a single anti-Vascular Endothelial Growth Factor injection on neonatal growth and organ development: In-vivo study. Exp Eye Res 2018 04;169:54-59
    Khalili S et al
    2018/01/01
  • 備考:
    Species: Rat, Applications: In Vivo
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Asano D et al. Cellular Mechanisms of Angiogenesis in Neonatal Rat Models of Retinal Neurodegeneration. Int J Mol Sci 2019 Sep;20(19)
    Asano D et al
    2019/01/01
  • 備考:
    Species: Rat, Applications: ICC
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Advani A et al. Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions. Proc. Natl. Acad. Sci. U.S.A. 2007 Sep;104(36):14448-53
    Advani A et al
    2007/01/01
  • 備考:
    Species: Rat, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Wang H et al. Quantitative analyses of retinal vascular area and density after different methods to reduce VEGF in a rat model of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2014 Feb;55(2):737-44
    Wang H et al
    2014/01/01
  • 備考:
    Species: Rat, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Hartnett ME et al. Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease. Invest. Ophthalmol. Vis. Sci. 2008 Jul;49(7):3107-14
    Hartnett ME et al
    2008/01/01
  • 備考:
    Species: Rat, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Baron-Menguy C et al. Effects of red wine polyphenols on postischemic neovascularization model in rats: low doses are proangiogenic, high doses anti-angiogenic. FASEB J. 2007 Nov;21(13):3511-21
    Baron-Menguy C et al
    2007/01/01
  • 備考:
    Species: Rat, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    McCloskey M et al. Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2013 Mar;54(3):2020-6
    McCloskey M et al
    2013/01/01
  • 備考:
    Species: Rat, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Melly L et al. Myocardial infarction stabilization by cell-based expression of controlled Vascular Endothelial Growth Factor levels. J. Cell. Mol. Med. 2018 May;22(5):2580-2591
    Melly L et al
    2018/01/01
  • 備考:
    Species: Rat, Applications: IHC
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Imberti B et al. Renal primordia activate kidney regenerative events in a rat model of progressive renal disease. PLoS ONE 2015;10(3):e0120235
    Imberti B et al
    2015/01/01
  • 備考:
    Species: Rat, Applications: IHC
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Shimojo N et al. Contributory role of VEGF overexpression in endothelin-1-induced cardiomyocyte hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 2007 Jul;293(1):H474-81
    Shimojo N et al
    2007/01/01
  • 備考:
    Species: Rat, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Deliyanti D et al. FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy. PLoS ONE 2015;10(7):e0134392
    Deliyanti D et al
    2015/01/01
  • 備考:
    Species: Rat, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Mirabelli P et al. Genome-wide expression differences in anti-Vegf and dexamethasone treatment of inflammatory angiogenesis in the rat cornea. Sci Rep 2017 Aug;7(1):7616
    Mirabelli P et al
    2017/01/01
  • 備考:
    Species: Rat, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Yeh WL et al. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression. Mol. Pharmacol. 2007 Aug;72(2):440-9
    Yeh WL et al
    2007/01/01
  • 備考:
    Species: Rat, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Lind T et al. Bones in human CYP26B1 deficiency and rats with hypervitaminosis A phenocopy <i>Vegfa</i> overexpression. Bone Rep 2018 Dec;9:27-36
    Lind T et al
    2018/01/01
  • 備考:
    Species: Rat, Applications: IHC
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Yeh WL et al. Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia. Mol. Pharmacol. 2008 Jan;73(1):170-7
    Yeh WL et al
    2008/01/01
  • 備考:
    Species: Rat, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Daniel C et al. Long-term gene therapy with thrombospondin 2 inhibits TGF-&#x3B2; activation, inflammation and angiogenesis in chronic allograft nephropathy. PLoS ONE 2013;8(12):e83846
    Daniel C et al
    2013/01/01
  • 備考:
    Species: Rat, Applications: IHC
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Irani Y et al. Production of scFv antibody fragments from a hybridoma with functional activity against human vascular endothelial growth factor. Hybridoma (Larchmt) 2009 Jun;28(3):205-9
    Irani Y et al
    2009/01/01
  • 備考:
    Species: Human, Applications: Binding Assay
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Westenbrink BD et al. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure. Cardiovasc. Res. 2010 Jul;87(1):30-9
    Westenbrink BD et al
    2010/01/01
  • 備考:
    Species: Rat, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Lin HH et al. Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1. J. Mol. Cell. Cardiol. 2008 Jul;45(1):44-55
    Lin HH et al
    2008/01/01
  • 備考:
    Species: Mouse, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Dharmani P et al. The probiotic mixture VSL#3 accelerates gastric ulcer healing by stimulating vascular endothelial growth factor. PLoS ONE 2013;8(3):e58671
    Dharmani P et al
    2013/01/01
  • 備考:
    Species: Rat, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Marko SB et al. VEGF promotes vascular sympathetic innervation. Am. J. Physiol. Heart Circ. Physiol. 2008 Jun;294(6):H2646-52
    Marko SB et al
    2008/01/01
  • 備考:
    Species: Rat, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Al Asoom LI. Coronary angiogenic effect of long-term administration of Nigella sativa. BMC Complement Altern Med 2017 Jun;17(1):308
    Al Asoom LI
    2017/01/01
  • 備考:
    Species: Rat, Applications: IHC
  • 参照:
    PubMed